Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Sep 11, 2023

BUY
$225.82 - $368.51 $4.97 Million - $8.11 Million
22,000 New
22,000 $5.59 Million
Q4 2021

Feb 17, 2023

BUY
$225.82 - $368.51 $4.97 Million - $8.11 Million
22,000 New
22,000 $5.59 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Artemis Wealth Advisors, LLC Portfolio

Follow Artemis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.